Data is not available at this time.
MEMSCAP, S.A. operates in the semiconductor industry, specializing in micro-electro-mechanical systems (MEMS) solutions tailored for aerospace, defense, optical communications, medical, and IT/consumer markets. The company generates revenue through a diversified portfolio of pressure sensors, transducers, and switches, alongside optical MEMS chips and custom manufacturing services. Its products serve critical applications such as air data computers, spinal pressure monitoring, and optical telecommunication networks, positioning MEMSCAP as a niche player in high-precision MEMS technology. The company caters to Fortune 500 firms, research institutions, and universities, leveraging its expertise in MEMS fabrication and prototyping. MEMSCAP’s market position is reinforced by its proprietary multi-user MEMS processes (MUMPs), which offer scalable solutions for industrial and biomedical applications. Despite its specialized focus, the company competes in a broader semiconductor landscape dominated by larger players, relying on innovation and customization to maintain its foothold.
MEMSCAP reported revenue of €12.66 million for the period, with net income of €1.37 million, reflecting a net margin of approximately 10.8%. The company’s operating cash flow stood at €548,000, while capital expenditures were modest at €206,000, indicating disciplined spending. Diluted EPS of €0.18 suggests stable earnings power, though cash flow generation remains relatively constrained compared to net income.
The company’s earnings are driven by its high-margin MEMS solutions, particularly in aerospace and medical applications. With a beta of 0.858, MEMSCAP exhibits lower volatility than the broader market, aligning with its niche focus. However, capital efficiency is tempered by limited operating cash flow relative to net income, suggesting potential working capital or reinvestment needs.
MEMSCAP maintains a balanced financial position, with €3.96 million in cash and equivalents against total debt of €5.05 million. The modest debt level and lack of dividend payouts provide flexibility, though liquidity remains tight given the company’s market capitalization of €27.38 million. The absence of significant capital expenditures underscores a conservative approach to growth funding.
Growth appears steady but unspectacular, with revenue and profitability metrics suggesting incremental progress. The company does not pay dividends, opting to reinvest earnings into its MEMS technology and custom solutions. This aligns with its focus on R&D and niche market expansion, though scalability remains a challenge given its specialized offerings.
At a market cap of €27.38 million, MEMSCAP trades at a P/E multiple of approximately 20x, reflecting investor expectations for sustained profitability in its niche markets. The low beta suggests muted sensitivity to broader market swings, but limited liquidity and small-cap status may deter larger investors.
MEMSCAP’s strategic edge lies in its specialized MEMS technology and custom fabrication services, which cater to high-barrier industries like aerospace and medical devices. The outlook hinges on its ability to innovate and scale its proprietary processes, though competition from larger semiconductor firms poses a persistent risk. Near-term growth will likely depend on demand for precision sensors in defense and healthcare applications.
Company description, financial data provided
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |